Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

NCT00674141 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

10

Enrollment

OTHER

Sponsor class

Stopped was not approved by the ministry of health

Conditions

MS Patient With Relpasing Remitting Attacks

Interventions

DRUG: Dexamethasone soduim phosphate

Sponsor

Hadassah Medical Organization